Children like Kiran Grover, who we met in 2016 at 1.5 years old, just 9 months after he had been diagnosed with cystic fibrosis. At that time, Kiran’s rare mutations meant he was not eligible for current CFTR modulators. Â
 Â
Today, Kiran’s life looks quite a bit different. Last fall, he became eligible to start Trikafta®, and as a result, has been able to gain weight. A very active 8-year-old, he loves golf, lacrosse, skiing, and soccer. Â
 Â
The progress we’ve made would not be possible without people like you. This 65 Roses Day, let’s sustain progress together. Join our 65 Roses Club by giving monthly to help accelerate innovative research as we work to advance more therapies and ultimately a cure.